![Christina Cognata-Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christina Cognata-Smith is the founder and currently holds the position of Chief Scientific Officer at DAS Therapeutics, Inc. which is founded in 2019.
| Empresas | Cargo | Inicio |
|---|---|---|
DAS Therapeutics, Inc.
 DAS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage pharmaceutical company | Fundador | 01/01/2019 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 1 |
|---|---|
DAS Therapeutics, Inc.
DAS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage pharmaceutical company | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
